CountryOfPapers CountryOfPapers
Journal list Promote
verified COP 2,7 · Q2 • database Scopus / SJR & Web of Science & DOAJ indexed
Diabetes Therapy
United States · Springer Publishing Company
workspace_premium Q2 — Internal Medicine visibility_off Double blind peer review lock_open Open Access · DOAJ

Diabetes Therapy

Diabetes Therapy is a journal indexed in SJR in Endocrinology, Diabetes and Metabolism and Internal Medicine with an H index of 59. It is an CC BY-NC Journal with a Double blind peer review review system, and It has a price of 3080 €. The scope of the journal is focused on diabetes, obesity, metabolic syndromes, type 1 diabetes, type 2 diabetes. It has a COP Index of 2,7 (best band Q2). It is published in English. It has a COP Index of 2,7.

ISSN: 1869-6953
Publisher: Springer Publishing Company
Category: Endocrinology, Diabetes and Metabolism
Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
COP Index trending_up
2,7 Q2

49 of 125 journals in Internal Medicine

H-index · SJR 59 · 1,07
Acceptance rate pie_chart
33%
Source Acceptance_Rate
Time to publication hourglass_top
6 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
3.080 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

COP Index

2,7

Q2

SJR Impact

1,07

H-index

59

Docs (year)

168

Docs 3y

499

Total refs

6838

Cites 3y

1534

Citable 3y

465

Cites/Doc 2y

2.62

Ref/Doc

40.7

Immediate OA

3080 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cardiovascular Risk in Type 1 Diabetes Mellitus

View more

Value of Capillary Glucose Profiles in Assessing Risk of Nocturnal Hypoglycemia in Type 1 Diabetes Based on Continuous Glucose Monitoring

View more

Correction to: Comparison of Adipose Distribution Indices with Gold Standard Body Composition Assessments in the EMPA-REG H2H SU Trial: A Body Composition Sub-Study

View more

Correction to: Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons

View more

Correction to: Bedtime-to-Morning Glucose Difference and iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of LixiLan-L

View more

Correction to: A Practical Guide to Delivering Nutritional Advice to People with Diabetes

View more

Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical Trials

View more

Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study

View more

Comparative Efficacy of Adding Sitagliptin to Metformin, Sulfonylurea or Dual Therapy: A Propensity Score-Weighted Cohort Study

View more

Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus

View more

Clinical Efficacy and Parameters Affecting the Response to Dulaglutide Treatment in Patients with Type 2 Diabetes: A Retrospective, Real-World Data Study

View more

Clinical Effects of Liraglutide in a Real-World Setting in Spain: eDiabetes-Monitor SEEN Diabetes Mellitus Working Group Study

View more
SHOW MORE ARTICLES

Changing Patients' Treatment Preferences and Values with a Decision Aid for Type 2 Diabetes Mellitus: Results from the Treatment Arm of a Randomized Controlled Trial

View more

A Retrospective Study of Glucagon-Like Peptide 1 Receptor Agonists for the Management of Diabetes After Transplantation

View more

Cardiac Versus Non-Cardiac Related Mortality Following Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis

View more

Basal Insulin Intensification in Patients with Type 2 Diabetes: A Review

View more

Association Between Maternal Glucose/Lipid Metabolism Parameters and Abnormal Newborn Birth Weight in Gestational Diabetes Complicated by Preeclampsia: A Retrospective Analysis of 248 Cases

View more

Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a 'Case Study'

View more

Aspirin Versus Clopidogrel Monotherapy for the Secondary Prevention of Recurrent Cerebrovascular Attack Following Previous Ischemic Stroke in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

View more

An RCT Investigating Patient-Driven Versus Physician-Driven Titration of BIAsp 30 in Patients with Type 2 Diabetes Uncontrolled Using NPH Insulin

View more

Adverse Changes in HbA1c, Body Weight and Insulin Use in People with Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme

View more

Adherence to Insulin, Emotional Distress, and Trust in Physician Among Patients with Diabetes: A Cross-Sectional Study

View more

Accuracy Evaluation of CONTOUR®PLUS Compared With Four Blood Glucose Monitoring Systems

View more

A Survey of Patient Preferences for Oral Antihyperglycemic Therapy in Patients with Type 2 Diabetes Mellitus

View more

FAQs